The Week In Biopharma, May 23 – 27
Contract Research (CROs)
- AmerisourceBergen aims to connect trial sponsors with cancer practices (USA)
- Terremoto spells out plan to expand covalent drug alphabet with $75M funding (USA)
- Agilex Biolabs Doubles in Size with Launch of New Large Molecule Facility as It Expands in the (USA)
Contract Development and Manufacturing (CDMO)
- KDx Diagnostics Inc. and UroGPO Announce a Partnership to Offer the URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States (USA)
- CPDC Enters Clinical Manufacturing Deal with CellBion (Barbados/South Korea)
- Olon to Build New R&D Center in (Italy)
- Hanmi Fine Chemical Launches CDMO Business (South Korea)
- Roche rolls out trio of PCR research tests for monkeypox (Switzerland)
- Medtronic joins forces with DaVita to launch new kidney tech company (Ireland/USA)
- Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia (France)
- Multiomics startup Pleno nabs $15M for a telecom-based approach to analyzing DNA, RNA (USA)
- Clinigen Expands U.S. Site Capacity (UK)
- INCOG BioPharma Services Opens Biomanufacturing Facility (USA)
- Lonza, IBF Partner on Drug Development, Manufacture for Portfolio Cos (Israel/Switzerland)
- Dexcom, Insulet in talks to merge into a diabetes device behemoth: report (USA)
- Illumina obtains European companion diagnostic test approval for Bayer rare cancer drug Vitrakvi (USA)
- Innoviva buys struggling antibiotic biotech Entasis, as the AstraZeneca spinout preps FDA filing (USA)
- GE Healthcare signs up to distribute HistoSonics’ soundwave therapy for liver cancer (USA)
- One year into Philips’ ventilator foam recall, FDA tallies 124 deaths, 21,000 complaints (USA)
- Thermo Fisher, Qatar Genome Program Partner to Advance Precision Medicine (USA/Qatar)
- CPC Launches AseptiQuik Genderless Connector (USA)
Biopharma
- Kintara Announces First European Site Activation in Switzerland in GCAR Phase 2/3 Clinical Trial for Glioblastoma (Switzerland)
- Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio (USA)
- Iovance hammered as cell therapy disappoints (USA)
- iECURE Enters Agreement with Center for Breakthrough Medicines (USA)
- FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma (Switzerland)
- Lilly to expand, add jobs with two new factories in Indiana (USA)
- CorePath Laboratories Announces Partnership with Cizzle Biotechnology to Develop Simple Blood Test for Early Lung Cancer Detection (USA)
- NovoMedix Receives Research Grant from the National Institutes of Health (NIH) to Advance NMX1 in TBNC (USA)
- Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform (China)
- Avadel’s shares crumble as narcolepsy drug delayed yet again, this time on patent issue (Ireland)
- Vertex scoops up Catalyst’s complement pipeline for $60M cash (USA)
- NRx tanks as peptide fails NIH trial in severe COVID-19 patients (USA)
- Flagship unveils ProFound Therapeutics with $75M to explore trove of new proteins (USA)
- Helsinn Establishes New R&D Hub in the (USA)
- CureVac, myNEO Partner on Antigen Targets for mRNA-Cancer Vax Development (Germany/Belgium)
- DFE Pharma Opens India CoE for Fast-Track Formulation Services (India
- Castle Creek Biosciences Raises $112.8 Million to Advance Novel Gene Therapies and Expand Pipeline (USA)
- Oxford BioTherapeutics Announces Collaboration with Agenus to Support the Clinical Development of OBT’s Antibody Drug Conjugate OBT076 in combination with Agenus’ CPI Balstilimab (USA)
- Ellipses Pharma and SunRock Biopharma Enter Into a Licensing Agreement for a First-in-class Bifunctional HER3:TRAIL Fusion Protein (UK/Spain)
- FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults (USA)
- European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment (USA)
- KaliVir Immunotherapeutics Enters into Global Exclusive Licensing Agreement with Roche for Novel Oncolytic Viruses (USA/Switzerland)
- Halozyme Completes Antares Pharma Acquisition (USA)
- Integral Molecular Breaks Ground on New Headquarters, Doubling in Size (USA)
- Genocea closes up shop after failing to find a buyer, delists from Nasdaq (USA)
- Supply chain challenges upend Caladrius’ coronary artery disease trial (USA)
- Manufacturing concerns sideline INmune’s US Alzheimer’s trial (USA)
- Synexa buys Syrinx to capture share of growing bioanalysis market (South Africa)
- Biohaven flunks first clinical test for rare disease drug post-Pfizer sell-off (USA)
- ImmunoGen Announces Acceptance of Biologics License Application for Mirvetuximab Soravtansine in Ovarian Cancer by US Food and Drug Administration with Priority Review (USA)
- Vaxzevria approved in the EU as third dose booster against COVID-19 (UK)
- Aptamer Group and PinotBio Extend Collaboration Agreement (UK/South Korea)
Artificial Intelligence
- Mayo Clinic, Janssen AI to detect pulmonary hypertension scores FDA breakthrough nod (USA)
- PharmEnable announces multi-target collaboration with Denali Therapeutics in neurodegenerative disease (UK/USA)
- Cardio Diagnostics Announces Headquarters Relocation to Chicago (USA)
- RapidAI speeds up pulmonary embolism diagnosis with FDA clearance for AI triage tool (USA)
- Fairtility™ Closes $15 Million Series A Funding Round (Israel)
